Clinical Trial Update: Vorinostat in Treating Patients With Kidney Cancer [Phase 2]

View source ↗

Summary

This document reports the results of a Phase 2 clinical trial of Vorinostat in patients with recurrent or stage IV renal cell carcinoma. Results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Vorinostat (Zolinza) (vorinostat)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-08-30